SCHEMBL6256705

SCHEMBL6256705

CCCCCCCNC(=O)N(C)c1cccc(-c2ccc(Nc3cccc(C)c3C(=O)N3CCC(C)CC3)cc2)c1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 3/20 0.37
SMO Q99835 1/20 0.36
ALK Q9UM73 2/20 0.33
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
RAB9A P51151 1/20 0.33
HPGD P15428 1/20 0.33
ITGB1 P05556 1/20 0.32
ITGA4 P13612 1/20 0.32
HRH3 Q9Y5N1 2/20 0.32
EPHX2 P34913 1/20 0.32
ADRB3 P13945 1/20 0.32
BRD4 O60885 1/20 0.32
CREBBP Q92793 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5355925 0.89 SMO (0.47) SMOALKLMNAALDH1A1GAA
SCHEMBL5359709 0.79 NAMPT (0.35) SMOKDM4EHPGDHRH3
SCHEMBL5355418 0.79 ALDH1A1 (0.41) SMOLMNASMN1; SMN2KDM4EALDH1A1
SCHEMBL5362472 0.78 ALDH1A1 (0.42) SMOLMNASMN1; SMN2KDM4EALDH1A1
SCHEMBL5360965 0.76 LTB4R2 (0.44) HPGD
SCHEMBL3439010 0.76 PLG (0.37) GAAHPGDADRB3
SCHEMBL3439009 0.76 PLG (0.37) GAAHPGDADRB3
SCHEMBL5355393 0.75 LTB4R2 (0.45) KDM4EHPGD
SCHEMBL3949408 0.75 PLG (0.36) GAAHPGDHRH3ADRB3
SCHEMBL5365094 0.75 SIRT2 (0.46) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1572629-A1 COMPOUNDS WHICH MODULATE PPARϝ TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS Galderma Research & Development, S.N.C. (FR) 2005-09-14 EP claimed
WO-2004052840-A1 COMPOUNDS WHICH MODULATE PPARϜ TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2004-06-24 WO claimed